Bearish flow noted in aTyr Pharma (ATYR) Inc with 5,906 puts trading, or 1.2x expected. Most active are Sep-25 2 puts and Sep-25 7 calls, with total volume in those strikes near 2,900 contracts. The Put/Call Ratio is 1.55, while ATM IV is up nearly 6 points on the day. Earnings are expected on November 6th.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATYR:
- aTyr Pharma price target raised to $17 from $9 at Jefferies
- Optimistic Buy Rating for aTyr Pharma Amid Promising EFZO-FIT Trial Prospects
- Optimistic Outlook for aTyr Pharma Amidst Controversies: Analyst Highlights Potential in EFZO-FIT Study
- Optimistic Buy Rating for aTyr Pharma Amid Promising Phase 3 Data and Innovative Sarcoidosis Treatment Approach
- Promising Developments and Strong Financial Position Drive Buy Rating for aTyr Pharma